Voraxaze

Voraxaze

Voraxaze 1,000 units powder for solution for injection.

As per the SPC Voraxaze is indicated to reduce toxic plasma methotrexate concentration in adults and children (aged 28 days and older) with delayed methotrexate elimination or at risk of methotrexate toxicity.

Voraxaze is distributed in Ireland by Fannin Ltd in partnership with Serb (This link will take you a non-Fannin Ltd website.  Fannin Ltd does not recommend, endorse or accept liability for sites controlled by third-parties.)

Method of Sale: POM

License Number: EU/1/21/1586/001

MAH Holder: SERB SAS, 40 Avenue George V, 75008 Paris, France

IE2024/105/00

Additional information available on request. Please contact medical@dccvital.com or telephone 01-2907000.

Date of preparation: June 2024